The value of serological markers in the diagnosis and prognosis of endometriosis: a prospective case–control study

Razvan Socolov, Socolov R, Răzvan Socolov, Butureanu S, Stefan Butureanu, S Buţureanu, Stefano Angioni, Sefano Angioni, Allia Sindilar, Sindilar A, Lucian Boiculese, Lucian Vasile Boiculese, Cozma L, Laurette Cozma, Socolov D, Demetra Socolov
European journal of obstetrics, gynecology, and reproductive biology · 2010 · vol. 154(2) , pp. 215–217 · doi:10.1016/j.ejogrb.2010.10.008 · PMID:21075501 · W2080757867
article OA: closed CC0 ⤵ 52 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-06 ⓘ

This prospective case-control study investigated the diagnostic and prognostic utility of serological markers in endometriosis patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveWe analyzed selected well-known and less well-known serum markers that have been proposed for diagnosis and severity assessment of endometriosis, in a case-control study.Study designThis prospective study was carried out in a Clinical Department of Gynecology in Iasi, Romania. Study participants included endometriosis patients, and controls in whom laparoscopy had excluded endometriosis. Each case and control was investigated for serum levels of CA125, TNF, IL-1, IL-6 and IL-8. The data were correlated with clinical symptoms and revised American Fertility Society (rAFS) score and stage, and interpreted by Mann-Whitney U-test and ANOVA regression analysis.ResultsOver the course of 1 year, 24 cases of endometriosis and 24 controls of matched age were selected. The rAFS stages were: stage I, 12.5%; stage II, 16.7%; stage III, 58.3%; and stage IV, 12.5%. CA125 levels were over the cut-off of 35 IU/l in 54% of patients (versus 8% of controls), averaging 67.5 (CI95: ±17.5). The sensitivity and specificity were 54% and 91%, respectively, with a p value of <0.001 (statistically significant). For IL-6, 71% of cases and 87% of controls were above the cut-off of 2 pg/ml, with an average of 11.83 ± 7. The sensitivity and specificity were 71% and 12%, respectively, but the difference was not statistically significant, p = 0.071. Other tested serum markers had no discrimination value. A correlation with severity of endometriosis was seen for CA125 (p = 0.03) but not for IL-6, by ANOVA.ConclusionCA125 correlated with endometriosis screening and severity, indicating its superiority as a marker for further, larger studies.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Biomarkers CA-125 Antigen Endometriosis Adult Biomarkers CA-125 Antigen Case-Control Studies Endometriosis Endometriosis Female Humans Interleukin-1 Interleukin-1 Interleukin-6 Interleukin-6 Interleukin-8 Interleukin-8 Prognosis Prospective Studies Sensitivity and Specificity

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (16)

Cited by (50)

Source provenance

europepmc
last seen: 2026-09-16T06:11:32.772430+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:16:54.825375+00:00
unpaywall
last seen: 2026-09-16T06:28:21.314993+00:00
License: CC0 · commercial use OK